Lisocabtagene Maraleucel (liso-cel) Versus Standard of Care (SOC) with Salvage Chemotherapy Followed By Autologous Stem Cell Transplantation (ASCT) As Second-Line (2L) Treatment in Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL): Primary Analysis of the Randomized, Phase 3 Transform Study

被引：8

作者：

Abramson, Jeremy S. ^{[1
]}

Solomon, Scott R. ^{[2
]}

Arnason, Jon E. ^{[3
]}

Johnston, Patrick B. ^{[4
]}

Glass, Bertram ^{[5
]}

Bachanova, Veronika ^{[6
]}

Ibrahimi, Sami ^{[7
]}

Mielke, Stephan ^{[8
,9
]}

Mutsaers, Pim ^{[10
]}

Hernandez-Ilizaliturri, Francisco ^{[11
]}

Izutsu, Koji ^{[12
]}

Morschhauser, Franck ^{[13
]}

Lunning, Matthew A. ^{[14
]}

Crotta, Alessandro ^{[15
]}

Montheard, Sandrine ^{[15
]}

Previtali, Alessandro ^{[15
]}

Kamdar, Manali ^{[16
]}

机构：

[1] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA

[2] Northside Hosp Canc Inst, Atlanta, GA USA

[3] Beth Israel Deaconess Med Ctr, Hematol Malignancy & Bone Marrow Transplantat Pro, Boston, MA USA

[4] Mayo Clin, Rochester, MN USA

[5] Helios Klinikum Berlin Buch, Berlin, Germany

[6] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA

[7] Univ Oklahoma, Stephenson Canc Ctr, Oklahoma City, OK USA

[8] Karolinska Inst, Stockholm, Sweden

[9] Univ Hosp, Karolinska Comprehens Canc Ctr, Stockholm, Sweden

[10] Erasmus MC, Rotterdam, Netherlands

[11] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[12] Natl Canc Ctr, Tokyo, Japan

[13] Ctr Hosp Univ Lille, Grp Rech Sur Formes Injectables & Technol Assoc, Lille, France

[14] Univ Nebraska, Omaha, NE USA

[15] Celgene, Boudry, Switzerland

[16] Univ Colorado, Canc Ctr, Aurora, CO USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-159702

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1581 / 1583

页数：3